Introduction
Celiac disease is a frequent, lifelong, primarily small intestinal enteropathy which is induced in genetically susceptible individuals after ingestion of wheat gluten. It is a multisystem disease and can develop at any point of time during life in genetically susceptible individuals upon ingestion of wheat gluten and related cereal proteins. 1, 2 Global prevalence is approximately 1-5% of the general population. 3 Celiac disease affecting patients is now well recognized in Northern India and prevalence is 1 in 96 (1.04%). 4 CD individuals may present gastrointestinal symptoms, extraintestinal symptoms or no sign or symptoms. About 50% of CD patients present extraintestinal or atypical symptoms, such as anaemia, osteoporosis, dermatitis herpetiformis, neurological problems and dental enamel hypoplasia. 5 Until the late 1970s, the suspicion of celiac disease was based mainly on clinical symptoms such as diarrhea, malabsorption and weight loss. Interestingly, a growing proportion of new cases of CD are being diagnosed in patients with extra intestinal manifestations. CD may affect several organs including kidney, skin, heart, nervous, endocrine and reproductive systems. 6 However, liver injury is one of the most frequent (15-55%) extra intestinal manifestations of the disease. 6 Based on the clinical features, serology and biopsy, celiac disease is classified as: 7 1. Classical celiac disease (dominated by gastrointestinal malabsorption) CD has become a wide spread public health problem. 12 Case finding for celiac disease in patients with liver disease is both cost-effective and beneficial in terms of quality of life. Early detection of this disease can prevent many of its unwanted complications. The current treatment for celiac disease is strict gluten free diet for life, although there is the possibility of alternate treatments. In the gluten-free diet wheat, barley and rye are to be avoided. The diagnosis should be definitive (i.e. proven by biopsy). In patients with celiac disease, mortality rate is higher than the general population. The important fact is that this mortality can be reduced to that of the general population after 1-5 years on a gluten free diet. 10, 11 So from this clinical point of view, early detection of celiac disease with serological testing or duodenal biopsy should be included in liver disease panel.
To the best of knowledge, there is a limited study in Bangladesh to find out the frequency of celiac disease in children with clinical and or biochemical features of liver disease. So from a clinical point of view, investigation of liver disease patients for celiac disease may be a valid approach.
Materials and Methods
Patients attending the Paediatric Gastroenterology and Nutrition department having clinical and biochemical features of liver disease were enrolled for the study. Patients clinical characteristics retrieved from medical interview, physical examinations and careful analysis of patients records. Patients who met the inclusion criteria and gave written consent to participate in the study were included in the study. Parents and the patients were informed about the nature of the study, its usefulness and its In patients with positive anti tTG (IgA) (titer of >50 iu/mL) were selected for upper GI endoscopy and biopsy from second part of duodenum. Patient who is IgA anti tTG negative but clinically susceptible, after excluding all other causes of liver dysfunction were selected for evaluation of serum IgA. Patient with serum IgA deficiency was also selected for upper GI endoscopy and biopsy from second part of duodenum. After 6-8 hours of fasting condition endoscopy of upper GIT were done using an Olympus forward viewing video endoscope under topical lignocaine anesthesia. During endoscopy, at least 2 biopsy fragments were taken from second part of duodenum and kept in a formalin filled test tube and were sent to the pathology department for histopathology. The endoscope & biopsy forceps were carefully cleaned and disinfected by immersing the scope in 2% glutaraldehyde for 20 minutes and then rinsing it with clean water. After half an hour of endoscopy and biopsy, patients were allowed to take at first liquid then semisolid and normal diet orally within two to three hours.
The small intestinal biopsy is considered the gold standard for diagnosis of CD using the modified Marsh criteria. 13 After exclusion of other causes of liver disease endoscopy of upper gastrointestinal tract (GIT) was done on patients who were tTG (titer of >50 iu/mL) positive. Endoscopy was done in 15 cases (endoscopy could not be done in 4 patients due to persistently raised PT) along with 1 patient who was IgA deficient. Endoscopic changes were mosaic and scalloping of D2 mucosa in 1 and 2 cases respectively and normal in others. Among 16 suspected CD patients, histological changes of intra epithelial lymphocytes (IEL) >30/100 enterocytes of duodenum were found in 11 (68.8%) patients and normal in 5 (31.3%) patients. Crypt hyperplasia were present in 8 (50%) cases and absent in others. Marsh 3a category was found in 2 (12.5%) cases and 3b in 3 (18.8%) cases.
Discussion
Celiac disease is (CD) a genetically determined chronic inflammatory disease induced by an environmental precipitant. The prevalence of hypertransaminasemia in patients with CD ranges between 15% and 61%, with the highest prevalence observed in children. Conversely, the prevalence of CD in patients with unexplained hypertransaminasemia is 10%, a finding that justifies screening for CD in all patients with abnormal liver biochemical test results. 8 The onset of symptom in the atypical form generally occurs between 4-15 years. This form commonly presents with short stature and refractory anaemia. None of the children had past history of chronic diarrhea. 14 In this study, frequency of celiac disease was evaluated among children with liver disease attending the Paediatric Gastroenterology and Nutrition department, BSMMU.
In the present study, 19 (32.2%) of 59 children had positive tTG (IgA) and mean age of 59 children was 8.33 ± 3.64 years. In a study in India, mean age at diagnosis of CD was 10.8 ± 2.2 (range 4-15) years, 14 and which is similar to the present study. Another study in India showed that CD with extraintestinal menifestations usually seen in older children or adolescent. 15 Out of 19 patients with positive tTG (IgA), male were 11 and female 8. Of 37 male patients, 29.7% and among 22 female children, 36.4% were positive for tTG (IgA). In the present study, girls were more likely than boys to had CD. There is no significant difference between male and female which is identical to the findings reported in Sahara 16 where it has been shown that a higher proportion of females were found to be positive for CD as compared to males. In the present study, it is shown that although the percentage of CD was more in female, sample size of male patients was greater in relation to female. This may be due to under reporting of symptoms in female patient in our country.
Among the studied children height for age Z score <-3 were seen in 19 (32.2%) cases and ≥-3 in 40 (67.8%) cases. It is statistically significant. Among 19 seropositive patients, 11 (57.9%) presented with short stature which is similar to the study done in India. 14 In that study, it has been shown that most of the patients of CD with extraintestinal manifestation commonly presented with short stature (4 out of 7 patients).
Histological changes compatible with CD were found in 5 (31.3%) patients. Marsh 3a category was found in 2 (12.5%) cases and 3b in 3 (18.8%) cases. In a study that was done in 4 cities in China, it has been reported that 2 patients with positive serology had no mucosal lesions. 17 One explanation regarding this finding may be that, a patient may have CD with normal duodenal biopsy and it may be due to patchy involvement of the duodenum. Another possibility is that a patient may have latent CD together with some degrees of gluten sensitivity. Another study done in India, 18 it has been reported that a good proportion of Indian children with CD had mild to moderate histological changes (Marsh 1 and 2) .
Early screening and identification of CD in at-risk groups can increase the level of awareness and capacity of physicians in recognizing various clinical presentations of CD and allow them to treat patients accordingly.
Limitations of the study Study was conducted on small sample size and no control patients were taken in this study.
Other serology was not investigated such as antiendomysial antibody and antigliadin antibody.
Conclusion
It can be concluded that celiac disease is an important cause of liver disease in the studied population which often remains undiagnosed. So, screening of celiac disease with serological testing or duodenal biopsy should be included in the diagnostic tests for evaluation of liver disease in children.
